Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 251 to 260 of 1412

TitleReference numberPublishedLast updated
Rimegepant for treating migraineTA919
Tofacitinib for treating active ankylosing spondylitisTA920
Ruxolitinib for treating polycythaemia veraTA921
Daridorexant for treating long-term insomniaTA922
Percutaneous deep venous arterialisation for chronic limb-threatening ischaemiaHTG698
Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatmentsTA927
Thyroid disease: assessment and managementNG145
Virtual ward platform technologies for acute respiratory infections: early value assessmentHTG697
Bimekizumab for treating active ankylosing spondylitis and non-radiographic axial spondyloarthritisTA918
Pegunigalsidase alfa for treating Fabry diseaseTA915

Results per page

  1. 10
  2. 25
  3. 50
  4. All